Opportunity Information: Apply for RFA MH 22 150

This NIH funding opportunity (RFA-MH-22-150; CFDA 93.242) supports research that strengthens established adolescent mental health treatments by layering in Just-in-Time Adaptive Interventions (JITAIs). The core idea is to take treatments that already have evidence behind them (for example, well-supported psychotherapies or structured behavioral interventions) and make them more potent, timely, and engaging for teenagers by delivering adaptive support in the moments it is most needed. The mechanism is an R61/R33 phased innovation award and it is a clinical trial required announcement, meaning applicants are expected to propose and carry out a clinical trial as part of the project, with an initial developmental/feasibility phase (R61) that can transition to a larger, more confirmatory phase (R33) if predefined milestones are met.

The scientific rationale is grounded in why adolescence is such a strategic window for this work. Adolescence is a period when many mental disorders first appear or worsen, when engagement and retention in traditional face-to-face care can be difficult, and when day-to-day technology use is extremely high. The FOA is essentially betting that real-time, technology-delivered supports can help close common gaps in adolescent care: missed appointments, limited between-session practice, low motivation, and the mismatch between what is taught in session and what happens in real-world contexts like school, home, peer situations, or online spaces. By focusing on developmentally informed and theoretically grounded approaches, NIH is signaling that proposals should not just be tech-forward, but should clearly explain the behavioral or clinical theory behind what the JITAI delivers, when it delivers it, and why that should improve outcomes.

JITAIs, as described here, are meant to capitalize on near-ubiquitous device access to deliver intervention content through platforms adolescents may find intrinsically motivating, and to do so in a way that is context-sensitive and personalized. In practice, that can include prompting brief skills practice in the situations where symptoms show up, using sensors or self-report check-ins to detect risk states, tailoring messages or micro-interventions to the adolescents current needs and preferences, and providing immediate feedback, reinforcement, or coaching. The FOA highlights several functions these systems can serve: helping adolescents practice skills in ecologically valid settings (not just in the clinic), adapting intensity or type of support moment-to-moment, and offering real-time scaffolding to reduce impairment as challenges arise. It also reflects the view that recent advances in mobile computing, wearables, and digital phenotyping make these designs more feasible than they were even a few years ago.

A notable point in the announcement is the stated evidence gap: despite promising results for JITAIs in other areas such as general health behavior change and addiction, there were no published studies of JITAIs for adolescent mental disorders at the time of the FOA description. That gap is part of what NIH is trying to address, positioning this as an emerging area of intervention science rather than an incremental improvement on an already mature evidence base. In other words, applications are expected to push the field forward by demonstrating how JITAIs can be integrated with established adolescent treatments and by generating clinical trial evidence on whether those enhancements improve engagement, skill use, symptoms, functioning, or other meaningful outcomes.

In terms of logistics and eligibility, this is a discretionary grant from the National Institutes of Health. The closing date listed in the source data is 2023-01-13, and the opportunity record was created 2021-11-15. A wide range of applicant organizations are eligible, including state, county, city, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other entities. The FOA also explicitly calls out additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, HBCUs, Tribally Controlled Colleges and Universities, faith-based or community-based organizations, certain tribal governments that are not federally recognized, U.S. territories or possessions, and even non-U.S. (foreign) organizations and regional organizations. The award ceiling and expected number of awards are not specified in the provided source fields, so applicants would typically need to consult the full FOA text for budget structure, milestone expectations, and review criteria tied to the R61/R33 transition.

Overall, the opportunity is aimed at teams that can combine clinical expertise in adolescent mental health, strong grounding in behavior change or clinical theory, and rigorous experimental methods with the technical ability to build and evaluate adaptive, real-time digital supports. The goal is not to replace established treatments, but to optimize them by extending their reach into the daily lives of adolescents, increasing timely skill delivery and practice, and improving outcomes through personalized, in-the-moment intervention components tested within a clinical trial framework.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Using Just-in-Time Adaptive Interventions to Optimize Established Adolescent Mental Health Treatments (R61/R33 Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
  • This funding opportunity was created on 2021-11-15.
  • Applicants must submit their applications by 2023-01-13. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA MH 22 150

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Mental Health Services

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)

Previous opportunity: Specialty Crop Research Initiative

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA MH 22 150

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA MH 22 150) also looked into and applied for these:

Funding Opportunity
Understanding Place-Based Health Inequalities in Mid-Life (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 004

Funding Number: RFA AG 23 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) Apply for RFA HL 23 008

Funding Number: RFA HL 23 008
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional) Apply for PAR 22 064

Funding Number: PAR 22 064
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Age-related Macular Degeneration (AMD) Integrative Biology Initiative: Discovery of AMD Pathobiology using Patient-Derived Induced Pluripotent Stem Cell (iPSC)-derived Retinal Pigment Epithelium (RPE) (U01 Clinical Trial Not Allowed) Apply for RFA EY 21 002

Funding Number: RFA EY 21 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed) Apply for RFA RM 22 006

Funding Number: RFA RM 22 006
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Basic Neurodevelopmental Biology of Circuits and Behavior (R01 Clinical Trial Not Allowed) Apply for PAR 22 066

Funding Number: PAR 22 066
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Network Clinical Center (Hub) (U24 Clinical Trial Not Allowed) Apply for RFA NS 22 015

Funding Number: RFA NS 22 015
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Limited Competition: Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Clinical Coordinating Center (CCC) (U24 Clinical Trial Not Allowed) Apply for RFA NS 22 014

Funding Number: RFA NS 22 014
Agency: National Institutes of Health
Category: Health
Funding Amount: $490,000
NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) Apply for RFA HL 23 009

Funding Number: RFA HL 23 009
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Basic Neurodevelopmental Biology of Circuits and Behavior (R21 Clinical Trial Not Allowed) Apply for PAR 22 067

Funding Number: PAR 22 067
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Limited Competition: Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Data Coordinating Center (DCC) (U24 Clinical Trial Not Allowed) Apply for RFA NS 22 013

Funding Number: RFA NS 22 013
Agency: National Institutes of Health
Category: Health
Funding Amount: $290,000
NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed) Apply for PAR 22 065

Funding Number: PAR 22 065
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Resource Networks for Protein Polymorphisms in Alzheimers Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed) Apply for RFA AG 22 030

Funding Number: RFA AG 22 030
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Continuation or Revision of NIDCR Clinical Trial Implementation Cooperative Agreement (UH3 Clinical Trial Required) Apply for PAR 22 068

Funding Number: PAR 22 068
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Research Resource for the National Swine Resource and Research Center (U42 Clinical Trial Not Allowed) Apply for PAR 21 356

Funding Number: PAR 21 356
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional) Apply for RFA HG 22 001

Funding Number: RFA HG 22 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Promoting Results and Outcomes through Policy and Economic Levers (PROPEL) Apply for 7200AA22APS00002

Funding Number: 7200AA22APS00002
Agency: Agency for International Development
Category: Health
Funding Amount: $180,000,000
Ocular Surface Innervation from Cell Types to Circuit Functions (U01 Clinical Trial Not Allowed) Apply for RFA EY 21 004

Funding Number: RFA EY 21 004
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional) Apply for RFA EB 21 001

Funding Number: RFA EB 21 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Research Centers in Minority Institutions (RCMI) (U54 Clinical Trials Optional) Apply for RFA MD 22 002

Funding Number: RFA MD 22 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 22 150", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: